Skip to main content
See every side of every news story
Published loading...Updated

Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to ...

MALVERN, Pa., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Bakersfield Californian broke the news in Bakersfield, United States on Wednesday, August 13, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal